Burning up TNF toxicity for cancer therapy
- 1 July 2002
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 8 (7) , 667-668
- https://doi.org/10.1038/nm0702-667
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- HSP70 Protects against TNF-Induced Lethal Inflammatory ShockImmunity, 2002
- Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2Proceedings of the National Academy of Sciences, 2000
- Heat shock proteins as cellular lifeguardsAnnals of Medicine, 1999
- Evidence for the involvement of endotheliai cell integrin αVβ3 in the disruption of the tumor vascuiature induced by TNF and IFN-γNature Medicine, 1998
- Heat Shock Protein–Peptide Complexes, Reconstituted In Vitro, Elicit Peptide-specific Cytotoxic T Lymphocyte Response and Tumor ImmunityThe Journal of Experimental Medicine, 1997
- Harly endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high‐dose tumour necrosis factor alpha (rTNFα)International Journal of Cancer, 1994
- Cachectin and tumour necrosis factor as two sides of the same biological coinNature, 1986
- An endotoxin-induced serum factor that causes necrosis of tumors.Proceedings of the National Academy of Sciences, 1975
- THE TREATMENT OF MALIGNAT TUMORS BY REPEATED INOCULATIONS OF ERYSIPELASThe Lancet Healthy Longevity, 1893